The company's announcement has limited immediate impact.
A team led by NIH scientists have reported a research trifecta.
The RESONATE-2 trial served as the basis for the March 2016 FDA approval of IMBRUVICA for the first-line treatment of CLL patients.
The research and educational collaboration will look particularly at applying next-generation sequencing to improve the health of communities.
A senior Republican lawmaker said Friday he'll unveil additional funding next week to battle the Zika virus in hopes of a quick vote in the GOP-controlled House.
A judge has unsealed records from a Kentucky lawsuit against the maker of the prescription painkiller OxyContin, including the secret testimony of a former company president.
GSK has a broad portfolio of approved meningococcal meningitis vaccines
The new research builds on an international clinical trial conducted 10 years ago.
Selumetinib inhibits the MEK pathway in cancer cells to prevent tumor growth.
The drugs have been sold for more than 20 years, and are now sold mainly as generics.
Gene therapy is based on the insertion of ad hoc genes into a host cell's genome so that these genes can function inside the cell by borrowing its genetic machinery.
UC Berkeley researchers have found a long-elusive Achilles' heel within "triple-negative" breast tumors, a common type of breast cancer that is difficult to treat.
A team of scientists from the Massachusetts Institute of Technology and Massachusetts General Hospital have devised an experimental polymer that has potential to change the dermatological field.
A drug that inhibits PRC2 might be able to treat metastatic breast cancer, where the enzyme may be overactive.
Standard drug development procedures are both expensive and time consuming and the success rates are low.